LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about T-knife Therapeutics

Similar companies to T-knife Therapeutics

T-knife Therapeutics Tech Stack

T-knife Therapeutics uses 8 technology products and services including DATEV, Google Hosted Libraries, MySQL, and more. Explore T-knife Therapeutics's tech stack below.

  • DATEV
    Accounting And Finance
  • Google Hosted Libraries
    Content Delivery Network
  • MySQL
    Database
  • PHP
    Programming Languages
  • Linux
    Programming Languages
  • Zoom
    Web Conferencing
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Media & News

T-knife Therapeutics's Email Address Formats

T-knife Therapeutics uses at least 1 format(s):
T-knife Therapeutics Email FormatsExamplePercentage
First.Last@t-knife.comJohn.Doe@t-knife.com
49%
First.MiddleLast@t-knife.comJohn.MichaelDoe@t-knife.com
1%
First.Middle@t-knife.comJohn.Michael@t-knife.com
1%
First.Last@t-knife.comJohn.Doe@t-knife.com
49%

Frequently Asked Questions

Where is T-knife Therapeutics's headquarters located?

Minus sign iconPlus sign icon
T-knife Therapeutics's main headquarters is located at San Francisco, US. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is T-knife Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
T-knife Therapeutics's official website is t-knife.com and has social profiles on LinkedIn.

How much revenue does T-knife Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, T-knife Therapeutics's annual revenue reached $15M.

What is T-knife Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
T-knife Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does T-knife Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, T-knife Therapeutics has approximately 76 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: T. S.Chief Scientific Officer: P. S.Vice President Corporate Development: M. P.. Explore T-knife Therapeutics's employee directory with LeadIQ.

What industry does T-knife Therapeutics belong to?

Minus sign iconPlus sign icon
T-knife Therapeutics operates in the Biotechnology Research industry.

What technology does T-knife Therapeutics use?

Minus sign iconPlus sign icon
T-knife Therapeutics's tech stack includes DATEVGoogle Hosted LibrariesMySQLPHPLinuxZoomApache HTTP ServerApache.

What is T-knife Therapeutics's email format?

Minus sign iconPlus sign icon
T-knife Therapeutics's email format typically follows the pattern of . Find more T-knife Therapeutics email formats with LeadIQ.

How much funding has T-knife Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, T-knife Therapeutics has raised $110M in funding. The last funding round occurred on Aug 02, 2021 for $110M.

When was T-knife Therapeutics founded?

Minus sign iconPlus sign icon
T-knife Therapeutics was founded in 2018.
T-knife Therapeutics

T-knife Therapeutics

Biotechnology ResearchSan Francisco, United States51-200 Employees

T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a modality that holds the potential to generate transformative responses in patients with solid tumors. The Company’s unique approach leverages its proprietary HuTCR mouse platform, a next-generation T cell receptor and epitope discovery engine that produces fully human, tumor-specific TCRs, naturally selected in vivo for optimal affinity and high specificity.

T-knife is advancing a portfolio of TCR-T product candidates against targets with high unmet medical need, including cancer testis antigens, oncoviral antigens and commonly shared tumor-driving neoantigens. T-knife was founded by leading T-cell and immunology experts using technology developed at the Max Delbruck Center for Molecular Medicine together with Charité – Universitätsmedizin Berlin.

Section iconCompany Overview

Headquarters
San Francisco, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $110M

    T-knife Therapeutics has raised a total of $110M of funding over 3 rounds. Their latest funding round was raised on Aug 02, 2021 in the amount of $110M.

  • $10M$50M

    T-knife Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    T-knife Therapeutics has raised a total of $110M of funding over 3 rounds. Their latest funding round was raised on Aug 02, 2021 in the amount of $110M.

  • $10M$50M

    T-knife Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.